Success Metrics

Clinical Success Rate
94.7%

Based on 89 completed trials

Completion Rate
95%(89/94)
Active Trials
23(18%)
Results Posted
27%(24 trials)
Terminated
5(4%)

Phase Distribution

Ph not_applicable
101
79%
Ph phase_2
12
9%
Ph phase_3
1
1%
Ph phase_4
6
5%
Ph phase_1
8
6%

Phase Distribution

8

Early Stage

12

Mid Stage

7

Late Stage

Phase Distribution128 total trials
Phase 1Safety & dosage
8(6.3%)
Phase 2Efficacy & side effects
12(9.4%)
Phase 3Large-scale testing
1(0.8%)
Phase 4Post-market surveillance
6(4.7%)
N/ANon-phased studies
101(78.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.8%

89 of 97 finished

Non-Completion Rate

8.2%

8 ended early

Currently Active

23

trials recruiting

Total Trials

128

all time

Status Distribution
Active(28)
Completed(89)
Terminated(8)
Other(3)

Detailed Status

Completed89
Recruiting14
Active, not recruiting9
Terminated5
Not yet recruiting4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
128
Active
23
Success Rate
94.7%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (6.3%)
Phase 212 (9.4%)
Phase 31 (0.8%)
Phase 46 (4.7%)
N/A101 (78.9%)

Trials by Status

withdrawn32%
completed8970%
terminated54%
not_yet_recruiting43%
unknown32%
enrolling_by_invitation11%
active_not_recruiting97%
recruiting1411%

Recent Activity

Clinical Trials (128)

Showing 20 of 128 trialsScroll for more
NCT05897788Not Applicable

Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

Active Not Recruiting
NCT06456905Not Applicable

Automated Reinforcement Management Systems, Phase II

Completed
NCT06239350Not Applicable

Young Adult Tobacco/Nicotine and Cannabis Co-use

Recruiting
NCT05181891Phase 2

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Recruiting
NCT07281378Not Applicable

Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

Not Yet Recruiting
NCT07340554Not Applicable

Neuroimaging of Adolescent Cannabis Use Treatment

Recruiting
NCT03528304Not Applicable

Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss

Completed
NCT06688539Phase 4

E-cigarette Cessation in Adults Who Co-use Cannabis

Recruiting
NCT05162391Not Applicable

Inflammation in Methamphetamine and STIs (IMSTI)

Completed
NCT07226596Not Applicable

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Recruiting
NCT07129902Not Applicable

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

Recruiting
NCT05445180Not Applicable

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

Recruiting
NCT04656925Not Applicable

Automated Reinforcement Management System (ARMS)

Completed
NCT02953899Not Applicable

Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers

Recruiting
NCT01789710Not Applicable

Contingency Management for Smoking Cessation in Homeless Smokers

Completed
NCT05396638Not Applicable

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

Active Not Recruiting
NCT06304467Not Applicable

CM for Patients With ALD After Liver Transplant

Active Not Recruiting
NCT05562557Not Applicable

A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

Recruiting
NCT07218471Not Applicable

Cannabis Reduction and Functional Outcomes

Recruiting
NCT04605458Not Applicable

Contingency Management to Promote Smoking Abstinence in Cancer Patients

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
128